findmyKOL

Mauricio Reinoso, MD, PA

Basic profile

Baylor College of Medicine

ORCIDNone on fileNPI
RegionSugar Land, TX · South CentralSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2000Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mauricio Reinoso is a Respiratory physician assistant affiliated with Baylor College of Medicine. OpenAlex indexes 7 publications with 601 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

601citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
27companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

16605 Southwest Fwy
Suite 310
Sugar Land, TX 774793501

Telephone

281-980-1330

Registry record last updated 5 Dec 2013.

View the NPPES registry record

Industry payments

27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    55.2%
    Corticosteroid32.5%
    Trelegy Ellipta35%Breo Ellipta31%Fluticasone Propionate11%Breztri Aerosphere9%Breyna5%Budesonide-Formoterol Fumarate5%Symbicort5%
    Part D<11 patients
    Leukotriene Receptor Antagonist12.1%
    Montelukast Sodium100%
    Part D57 patients

    + 2 more classes in this area

  • Nervous system

    25.3%
    Tricyclic Antidepressant7%
    Doxepin Hcl100%
    Part D22 patients
    gamma-Aminobutyric Acid A Receptor Positive Modulator4.6%
    Zolpidem Tartrate67%Zolpidem Tartrate Er33%
    Part D<11 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    9.8%
    Proton pump inhibitor4.9%
    Pantoprazole Sodium77%Omeprazole23%
    Part D<11 patients
    Corticosteroid3.5%
    Prednisone100%
    Part D33 patients

    + 1 more class in this area

Where care is delivered (Part B)7.7% facility · 92.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”